India, Oct. 8 -- China SXT Pharmaceuticals (SXTC) has entered into a definitive agreement with certain institutional investors to raise approximately $12 million through a registered direct offering, ... Read More
India, Oct. 8 -- Innovent Biologics announced that its Phase 3 RESTORE-3 study of SYCUME (teprotumumab N01 injection) met the primary endpoint in Chinese patients with inactive thyroid eye disease (TE... Read More
India, Oct. 8 -- Stocks have moved mostly lower during trading on Thursday, adding to the modest losses posted in the previous session. The major averages have all moved to the downside, with the Nasd... Read More
India, Oct. 8 -- Glaukos Corporation (GKOS) has entered into an exclusive licensing agreement with RevOpsis to develop and commercialize RO-104, a biologic being developed for several retinal diseases... Read More
India, Oct. 8 -- Sentiment soured in cryptocurrency markets amidst a brutal bond selloff and a surge in crude oil prices. Overall crypto market capitalization slipped around a percent in the past 24 h... Read More
India, Oct. 8 -- Wallix Group SA (ALLIX.PA) revealed Loss for first half of -EUR0.907 million The company's bottom line totaled -EUR0.907 million, or -EUR0.134 per share. This compares with -EUR3.098... Read More
India, Oct. 8 -- Myriad Genetics (MYGN) and SOPHiA GENETICS (SOPH) announced a collaboration with AstraZeneca (AZN) to advance a new prostate cancer-specific genomic instability score, or PrGIS, for p... Read More
India, Oct. 8 -- Thursday, Sudzucker AG (SUEZF.PK) announced its financial results for the first half of fiscal 2026/27, reporting consolidated group revenues of 4,188 million euros, down from last ye... Read More
India, Oct. 8 -- Cyprus' consumer price inflation accelerated further in September to the highest level in three years, preliminary data from the statistical office showed on Thursday. The consumer p... Read More
India, Oct. 8 -- Medicus Pharma (MDCX) marked its third anniversary as a public company by highlighting its transformation into a precision oncology-focused biotechnology company and outlining a strat... Read More